Five years after Clinical Trial Regulation (EU) first came into force, development of the clinical trials portal and database that will trigger its official application is about to begin. Subsequently, the pharmaceutical industry is at the brink of new regulations that will bring added complexity to the labelling of clinical trial supplies. Gordon Alexander & Simon Jones at PRISYM ID explain why the new regulations will need companies to rethink their clinical trial supply processes.